Epstein-Barr virus-associated lymphoma in patients with dermatomyositis. Be aware of double immunosuppression.
Selva-O'Callaghan
Albert
A
Palacios
Andrés
A
Solans-Laque
Roser
R
Labirua
Anne
A
Salcedo-Allende
Teresa
T
Vilardell-Tarrés
Miquel
M
D000328:Adult; D003882:Dermatomyositis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008223:Lymphoma / Q000821:virology*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications*
D007166:Immunosuppressive Agents